Predicción y previsión de precio de Hemab Therapeutics Holdings Inc (COAG)COAGHemab Therapeutics Holdings Inc

Alphio's COAG stock price prediction model matches the current Hemab Therapeutics Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $35.37 (+2.82%). The 1-week path is $34.06 (-0.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Hemab Therapeutics (COAG) is a good buy right now due to its current price of $34.40, which is significantly below the analyst consensus target mean of $62.42, suggesting a potential upside of 105.68%. Additionally, the stock has shown a strong year-to-date change of +91.11%, indicating positive momentum. However, the main risk is the negative earnings per share (EPS) of -1.00 reported in Q2 2026, which reflects ongoing financial challenges.

Hemab Therapeutics Holdings Inc (COAG) last closed at $34.4, losing -1.19%. These facts feed the 1-day and 1-week COAG price prediction above.